| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/08/2004 | CN1165548C Purification of human myocardial troponin I |
| 09/08/2004 | CN1165547C Novel lantibiotic related to actagardine, and process for preparation and use thereof |
| 09/08/2004 | CN1165340C Cartilage/bone inducing materials for reparation |
| 09/07/2004 | US6787687 Rin gene compositions and methods for use thereof |
| 09/07/2004 | US6787647 Carnitine carrier related protein-1 |
| 09/07/2004 | US6787646 Tumor suppressor molecules and methods of use |
| 09/07/2004 | US6787645 Platelet derived growth factors; for stimulating and/or enhancing immune responsiveness and in wound healing and related tissue repair; for tumor suppression, cancer treatment |
| 09/07/2004 | US6787643 Nucleic acid for use in kits for detection of preferential bacterial infection |
| 09/07/2004 | US6787642 Nucleotide sequences coding membrane protein for use in development of insecticides |
| 09/07/2004 | US6787641 Identification of sel-12 and uses thereof |
| 09/07/2004 | US6787640 Fibroblast growth factor 14 |
| 09/07/2004 | US6787639 Collectin |
| 09/07/2004 | US6787637 Comprises administering agents that induce beneficial |
| 09/07/2004 | US6787636 Modified serum albumin with reduced affinity for nickel and copper |
| 09/07/2004 | US6787634 Recognizes the extracellular domain of the human ifn-r and which has neutralizing capacity against the biological properties of human type i-ifn. |
| 09/07/2004 | US6787519 Methods of treating disorders related to apoE |
| 09/07/2004 | US6787357 Plasma-derived fibrin-based matrices and tissue |
| 09/07/2004 | US6787354 Diagnosing and detecting cancer in mammals; obtain cells, isolate nucleotide sequences, detect hepsin nucleotide sequences, the presence of hepsin indicates hyperplasia |
| 09/07/2004 | US6787352 Nucleotide sequences coding polypeptide fpr use in the human therapeutics, pharmacology, foods and animal feeds |
| 09/07/2004 | US6787351 Composition for the prevention of preferential viral infections |
| 09/07/2004 | US6787336 DNA encoding growth hormone antagonists |
| 09/07/2004 | US6787335 Polynucleotides and polypeptides which are diagnostic markers for mammary gland cancer. |
| 09/07/2004 | US6787333 Retrovirus isolated from humans |
| 09/07/2004 | US6787328 Methods and compositions relating to CD39-like polypeptides and nucleic acids |
| 09/07/2004 | US6787326 For destruction in normoxic but not hypoxic cells; promotes angiogenesis and/or cellular survival; fusion proteins |
| 09/07/2004 | US6787322 Integrin cell surface receptor for use as tool in the treatment of cancer |
| 09/07/2004 | US6787320 In vitro methods for determining in vivo thrombotic events |
| 09/07/2004 | US6787319 Nucleotide sequences coding polypeptide for use in the treatment of alzheimer's disease |
| 09/07/2004 | US6787317 Method of identifying missing domains in receptors |
| 09/07/2004 | US6787309 Nucleotide sequences coding cardiovascular protein for use in the diagnosis and treatment chromosomal disorder |
| 09/07/2004 | US6787303 Comprises polymerases, pol genes; for gene therapy |
| 09/07/2004 | US6787300 Identifying lifespan-altering agents |
| 09/07/2004 | US6787158 Process for treatment of a lactic raw material |
| 09/07/2004 | US6787145 Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 09/07/2004 | US6787142 Mutant human hepatitis B viral strain and uses thereof |
| 09/07/2004 | US6787141 Peptide having for fibrinogen fragment E activity, analogs, antibodies and uses thereof |
| 09/07/2004 | US6787137 Campylobacter vaccine |
| 09/07/2004 | US6787136 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| 09/07/2004 | US6787125 Dispensing nematode worms into multi-well plate containing carboxymethyl cellulose; contacting with chemical; detecting a signal indicating changes; drug screening; high throughput assay |
| 09/07/2004 | US6786726 Interactive dental restorative network |
| 09/07/2004 | CA2421321A1 Peptides associated with hla-dr mhc class ii molecule and involved in rheumatoid arthritis |
| 09/07/2004 | CA2087006C Nucleic sequences from the genome of salmonella typhi, and uses thereof particularly for the in vitro diagnosis of the presence of salmonella bacteria in foodstuffs |
| 09/02/2004 | WO2004074841A2 Kor3l-like-proteins and methods of modulating kor3l-mediated activity |
| 09/02/2004 | WO2004074514A2 Method of diagnosis of type 2 diabetes and early onset thereof |
| 09/02/2004 | WO2004074511A1 Diagnosis and treatment of baff-mediated autoimmune diseases and cancer |
| 09/02/2004 | WO2004074507A2 Method to confer cell culture replication activity to different hepatitis c virus isolates |
| 09/02/2004 | WO2004074494A1 Method of treating ischemic disease |
| 09/02/2004 | WO2004074488A1 Use of caspase enzymes for maturation of engineered recombinant polypeptide fusions |
| 09/02/2004 | WO2004074486A2 Fusion proteins of interferon alpha muteins with improved properties |
| 09/02/2004 | WO2004074484A1 Method of screening apoptosis-controlling agent |
| 09/02/2004 | WO2004074483A1 Tsg gene-knockout animal |
| 09/02/2004 | WO2004074481A1 Glycorpotein antigen sima135 expressed in metastatic human tumor cells |
| 09/02/2004 | WO2004074479A1 Methods of constructing biodiverse gene fragment libraries and biological modulators isolated therefrom |
| 09/02/2004 | WO2004074475A1 Cis-element regulating transcription, transcriptional regulatory factor binding specifically thereto and use of the same |
| 09/02/2004 | WO2004074473A1 Mutant receptor and process for producing the same, method of separately evalauting ligands with the use of mutant receptor and normal receptor, screening method and kit therefor. |
| 09/02/2004 | WO2004074462A2 Delta-endotoxin genes and methods for their use |
| 09/02/2004 | WO2004074461A2 Production of modified glycoproteins having multiple antennary structures |
| 09/02/2004 | WO2004074460A2 Nucleotide and protein sequences of coc genes and methods based thereon |
| 09/02/2004 | WO2004074459A2 Pten-deficient cells and their uses |
| 09/02/2004 | WO2004074458A2 N-acetylglucosaminyltransferase iii expression in lower eukaryotes |
| 09/02/2004 | WO2004074448A2 mTOR KINASE-ASSOCIATED PROTEINS |
| 09/02/2004 | WO2004074446A2 Parkin interacting polypeptides and methods of use |
| 09/02/2004 | WO2004074445A2 Model for studying the role of genes in tumor resistance to chemotherapy |
| 09/02/2004 | WO2004074441A2 Amplification or overexpression of mll septin-like fusion (msf) and septin9 and methods related thereto |
| 09/02/2004 | WO2004074437A2 Compositions and methods for cancer immunotherapy |
| 09/02/2004 | WO2004074436A2 Methods of use of a gpcr in the diagnosis and treatment of colon and lung cancer |
| 09/02/2004 | WO2004074433A2 Rag polypeptides, nucleic acids, and their use |
| 09/02/2004 | WO2004074432A2 Antibody vaccine conjugates and uses therefor |
| 09/02/2004 | WO2004074431A2 Plant ion channels and related methods |
| 09/02/2004 | WO2004074430A2 Compositions, splice variants and methods relating to lung specific genes and proteins |
| 09/02/2004 | WO2004074321A2 Therapeutic gpcr targets in cancer |
| 09/02/2004 | WO2004074320A2 Therapeutic targets in cancer |
| 09/02/2004 | WO2004074319A1 Physiologically active peptides and drugs containing the same |
| 09/02/2004 | WO2004074318A2 Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof. |
| 09/02/2004 | WO2004074316A1 Conformationally constrained backbone cyclized peptide analogs |
| 09/02/2004 | WO2004074315A2 Analogues of glp-1 |
| 09/02/2004 | WO2004074313A2 Methods for prediction of amyloid fibril formation and identification of peptides useful as therapeutic and diagnostic agents |
| 09/02/2004 | WO2004074312A2 Tryptophyllin peptides and uses thereof |
| 09/02/2004 | WO2004074310A2 Mycobacterial diagnostics |
| 09/02/2004 | WO2004074302A2 Autosomal recessive polycystic kidney disease nucleic acids and peptides |
| 09/02/2004 | WO2004074301A2 Differentially expressed nucleic acids that correlate with ksp expression |
| 09/02/2004 | WO2004074245A2 Monkey alpha-7 nicotinic acetylcholine receptor and methods of use thereof |
| 09/02/2004 | WO2004073742A1 Degradation inhibitor for hepatitis b virus x interacting protein |
| 09/02/2004 | WO2004073738A2 Composition to be administered to a living being and method for marking agents |
| 09/02/2004 | WO2004073736A1 Attenuated strains of vibrio cholerae and lyophilised vaccines containing same |
| 09/02/2004 | WO2004073734A1 Inhibition of tace or amphiregulin for the modulation of egf receptor signal transactivation |
| 09/02/2004 | WO2004073640A2 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 09/02/2004 | WO2004073609A2 Posh associated kinases and related methods |
| 09/02/2004 | WO2004073415A2 Water soluble animal muscle protein product |
| 09/02/2004 | WO2004057946A3 Method for altering the content of reserve substances in plants |
| 09/02/2004 | WO2004057018A3 Pseudomonas aeruginosa and klebsiella virulence genes, proteins, and their use |
| 09/02/2004 | WO2004052773A3 Peptide nanostructures, methods for their preparation and use |
| 09/02/2004 | WO2004046730A3 Uses of ble proteins and antibiotics from the bleomycin family |
| 09/02/2004 | WO2004046365A3 Interferon-alpha polypeptides and conjugates |
| 09/02/2004 | WO2004044166A3 Carbohydrate-associated proteins |
| 09/02/2004 | WO2004041845A3 Templated native silk smectic gels |
| 09/02/2004 | WO2004037987A3 Secreted proteins |
| 09/02/2004 | WO2004034971A9 Methods for treating and preventing sepsis using modified c1 inhibitor or fragments thereof |
| 09/02/2004 | WO2004029205A3 Structural and cytoskeleton-associated proteins |
| 09/02/2004 | WO2004026251A3 Process for decreasing aggregate levels of pegylated protein |